X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
tuberculosis (19) 19
index medicus (17) 17
adult (14) 14
female (14) 14
male (14) 14
tuberculosis, multidrug-resistant - drug therapy (14) 14
drug resistance (12) 12
infectious diseases (10) 10
middle aged (10) 10
multidrug-resistant tuberculosis (10) 10
antitubercular agents - therapeutic use (9) 9
care and treatment (9) 9
respiratory system (9) 9
mycobacterium tuberculosis - drug effects (8) 8
adolescent (7) 7
latvia (7) 7
patients (7) 7
risk factors (7) 7
drug resistance, multiple, bacterial (6) 6
drugs (6) 6
microbiology (6) 6
mycobacterium tuberculosis - isolation & purification (6) 6
research (6) 6
treatment outcome (6) 6
aged (5) 5
antitubercular agents - administration & dosage (5) 5
drug resistance in microorganisms (5) 5
drug therapy, combination (5) 5
health aspects (5) 5
immunology (5) 5
microbial sensitivity tests (5) 5
mycobacterium-tuberculosis (5) 5
public health (5) 5
pulmonary tuberculosis (5) 5
sputum - microbiology (5) 5
treatment failure (5) 5
tuberculosis, multidrug-resistant - microbiology (5) 5
tuberculosis, multidrug-resistant - mortality (5) 5
tuberculosis, pulmonary - drug therapy (5) 5
young adult (5) 5
drug therapy (4) 4
medicine (4) 4
medicine, general & internal (4) 4
multidrug resistant organisms (4) 4
patient outcomes (4) 4
prospective studies (4) 4
tuberculosis, multidrug-resistant - epidemiology (4) 4
analysis (3) 3
antitubercular agents (3) 3
article (3) 3
cohort studies (3) 3
dots-plus (3) 3
intervention (3) 3
latvia - epidemiology (3) 3
meta-analysis (3) 3
mortality (3) 3
odds ratio (3) 3
program (3) 3
pulmonary/respiratory (3) 3
recurrence (3) 3
retrospective studies (3) 3
rifampin (3) 3
studies (3) 3
treatment outcomes (3) 3
tuberculosis, pulmonary - mortality (3) 3
1103 clinical sciences (2) 2
2nd-line drugs (2) 2
adults (2) 2
and commentaries (2) 2
articles and commentaries (2) 2
bedaquiline (2) 2
clinical outcomes (2) 2
clinical trials (2) 2
clofazimine (2) 2
cohort (2) 2
confidence intervals (2) 2
countries (2) 2
diagnosis (2) 2
directly observed therapy (2) 2
disease control (2) 2
dosage and administration (2) 2
drug-resistance (2) 2
estonia - epidemiology (2) 2
europe (2) 2
europe, eastern - epidemiology (2) 2
experience (2) 2
extensively drug-resistant tuberculosis (2) 2
extensively drug-resistant tuberculosis - drug therapy (2) 2
fluoroquinolones - therapeutic use (2) 2
follow-up (2) 2
health (2) 2
human immunodeficiency virus--hiv (2) 2
infection (2) 2
infectious disease (2) 2
laboratories (2) 2
lung diseases (2) 2
management (2) 2
medical services (2) 2
medical treatment (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
by Ahmad, Nafees and Ahuja, Shama D and Akkerman, Onno W and Alffenaar, Jan-Willem C and Anderson, Laura F and Baghaei, Parvaneh and Bang, Didi and Barry, Pennan M and Bastos, Mayara L and Behera, Digamber and Benedetti, Andrea and Bisson, Gregory P and Boeree, Martin J and Bonnet, Maryline and Brode, Sarah K and Brust, James C M and Cai, Ying and Caumes, Eric and Cegielski, J Peter and Centis, Rosella and Chan, Pei-Chun and Chan, Edward D and Chang, Kwok-Chiu and Charles, Macarthur and Cirule, Andra and Dalcolmo, Margareth Pretti and D'Ambrosio, Lia and de Vries, Gerard and Dheda, Keertan and Esmail, Aliasgar and Flood, Jennifer and Fox, Gregory J and Fréchet-Jachym, Mathilde and Fregona, Geisa and Gayoso, Regina and Gegia, Medea and Gler, Maria Tarcela and Gu, Sue and Guglielmetti, Lorenzo and Holtz, Timothy H and Hughes, Jennifer and Isaakidis, Petros and Jarlsberg, Leah and Kempker, Russell R and Keshavjee, Salmaan and Khan, Faiz Ahmad and Kipiani, Maia and Koenig, Serena P and Koh, Won-Jung and Kritski, Afranio and Kuksa, Liga and Kvasnovsky, Charlotte L and Kwak, Nakwon and Lan, Zhiyi and Lange, Christoph and Laniado-Laborín, Rafael and Lee, Myungsun and Leimane, Vaira and Leung, Chi-Chiu and Leung, Eric Chung-Ching and Li, Pei Zhi and Lowenthal, Phil and Maciel, Ethel L and Marks, Suzanne M and Mase, Sundari and Mbuagbaw, Lawrence and Migliori, Giovanni B and Milanov, Vladimir and Miller, Ann C and Mitnick, Carole D and Modongo, Chawangwa and Mohr, Erika and Monedero, Ignacio and Nahid, Payam and Ndjeka, Norbert and O'Donnell, Max R and Padayatchi, Nesri and Palmero, Domingo and Pape, Jean William and Podewils, Laura J and Reynolds, Ian and Riekstina, Vija and Robert, Jérôme and Rodriguez, Maria and Seaworth, Barbara and Seung, Kwonjune J and Schnippel, Kathryn and Shim, Tae Sun and Singla, Rupak and Smith, Sarah E and Sotgiu, Giovanni and Sukhbaatar, Ganzaya and Tabarsi, Payam and Tiberi, Simon and Trajman, Anete and Trieu, Lisa and Udwadia, Zarir F and van der Werf, Tjip S and Veziris, Nicolas and Viiklepp, Piret and ... and The Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017 and Collaborative Grp Meta-Analysis In and Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 821 - 834
Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of... 
DRUG | SURGERY | SOUTH-AFRICA | BEDAQUILINE | MEDICINE, GENERAL & INTERNAL | HIGH-RATES | MANAGEMENT | SAFETY | XDR-TB | REGIMENS | PROGRAM | Clofazimine - therapeutic use | Recurrence | Tuberculosis, Multidrug-Resistant - mortality | Linezolid - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Kanamycin - therapeutic use | Moxifloxacin | Capreomycin - therapeutic use | Amikacin - therapeutic use | Carbapenems - therapeutic use | Tuberculosis, Pulmonary - mortality | Diarylquinolines - therapeutic use | Treatment Failure | Antitubercular Agents - administration & dosage | Levofloxacin - therapeutic use | Drug Therapy, Combination | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Patient outcomes | Analysis | Drugs | Fluoroquinolones | Linezolid | Levofloxacin | Amikacin | Medical services | Clinical trials | Systematic review | Drug resistance | Success | Clinical outcomes | Literature reviews | Heterogeneity | Kanamycin | Data analysis | Clofazimine | Adjustment | Mortality | Data processing | Thorax | Regression analysis | Disease control | Patients | Capreomycin | Meta-analysis | Studies | Multidrug resistant organisms | Infectious diseases | Adults | Respiration | Carbapenems
Journal Article
by Ahuja, Shama D and Ashkin, David and Avendano, Monika and Banerjee, Rita and Bauer, Melissa and Bayona, Jamie N and Becerra, Mercedes C and Benedetti, Andrea and Burgos, Marcos and Centis, Rosella and Chan, Eward D and Chiang, Chen-Yuan and Cox, Helen and D'Ambrosio, Lia and DeRiemer, Kathy and Dung, Nguyen Huy and Enarson, Donald and Falzon, Dennis and Flanagan, Katherine and Flood, Jennifer and Garcia-Garcia, Maria L and Gandhi, Neel and Granich, Reuben M and Hollm-Delgado, Maria G and Holtz, Timothy H and Iseman, Michael D and Jarlsberg, Leah G and Keshavjee, Salmaan and Kim, Hye-Ryoun and Koh, Won-Jung and Lancaster, Joey and Lange, Christophe and de Lange, Wiel C. M and Leimane, Vaira and Leung, Chi Chiu and Li, Jiehui and Menzies, Dick and Migliori, Giovanni B and Mishustin, Sergey P and Mitnick, Carole D and Narita, Masa and O'Riordan, Philly and Pai, Madhukar and Palmero, Domingo and Park, Seung-kyu and Pasvol, Geoffrey and Peña, Jose and Pérez-Guzmán, Carlos and Quelapio, Maria I. D and Ponce-de-Leon, Alfredo and Riekstina, Vija and Robert, Jerome and Royce, Sarah and Schaaf, H. Simon and Seung, Kwonjune J and Shah, Lena and Shim, Tae Sun and Shin, Sonya S and Shiraishi, Yuji and Sifuentes-Osornio, José and Sotgiu, Giovanni and Strand, Matthew J and Tabarsi, Payam and Tupasi, Thelma E and van Altena, Robert and van der Walt, Martie and van der Werf, Tjip S and Vargas, Mario H and Viiklepp, Pirett and Westenhouse, Janice and Yew, Wing Wai and Yim, Jae-Joon and Collaborative Grp Meta-Anal and Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
PLoS Medicine, ISSN 1549-1277, 08/2012, Volume 9, Issue 8, p. e1001300
Background: Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual... 
STANDARDIZED REGIMENS | PHILIPPINES | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SHORT-COURSE CHEMOTHERAPY | DOTS-PLUS | COHORT | DRUG-RESISTANCE | INTERVENTION | PROGRAM | Patient outcomes | Pulmonary tuberculosis | Physiological aspects | Research | Drug therapy | Drug resistance | Health aspects | Meta-analysis | Studies | Clinical trials | Tuberculosis
Journal Article
Lancet, ISSN 0140-6736, 01/2005, Volume 365, Issue 9456, pp. 318 - 326
Background Latvia has one of the highest rates of multidrug-resistant tuberculosis (MDRTB). Our aim was to assess treatment outcomes for the first full cohort... 
Journal Article
The European respiratory journal, ISSN 0903-1936, 05/2018, Volume 51, Issue 5, pp. 1702678 - 1702678
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2015, Volume 3, Issue 3, pp. 201 - 209
Journal Article
Pharmacy (Basel, Switzerland), ISSN 2226-4787, 01/2018, Volume 6, Issue 1, p. 9
The PHARMINE (" ") project studied the organisation of pharmacy practice and education in the member states of the European Union (EU). The work was carried... 
Drug stores | Pharmacy | pharmacy | practice | Latvia | education | European Union
Journal Article
Infection, Genetics and Evolution, ISSN 1567-1348, 03/2020, Volume 78, p. 104126
Although the number of new tuberculosis (TB) cases registered per year has decreased by 3-fold between 2001 and 2017 in Latvia, the TB incidence and rates of... 
Molecular epidemiology | Latvia | Tuberculosis | Genotyping | Drug resistance
Journal Article